Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging

Journal of Neuroscience Methods

Volumn 144, Issue 1, 2005, Pages 25-34

  Schiffer, Wynne K ^a,b   Alexoff, David L ^b   Shea, Colleen ^b   Logan, Jean ^b   Dewey, Stephen L ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

11C raclopride; D2 receptors; Mass effect; Microdialysis; MicroPET; Rodent

Indexed keywords

DOPAMINE; RACLOPRIDE; RACLOPRIDE C 11; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; EXTRACELLULAR FLUID; IMAGE ANALYSIS; MALE; MICRODIALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS;

EID: 17444393589     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.10.016     Document Type: Article

References (36)

1. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, and L.S. Kegeles Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc Natl Acad Sci USA 97 2000 8104 8109
2. D.L. Alexoff, P. Vaska, D. Marsteller, T. Gerasimov, J. Li, and J. Logan Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity J Nucl Med 44 2003 815 822
3. D.M. Araujo, S.R. Cherry, K.J. Tatsukawa, T. Toyokuni, and H.I. Kornblum Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease Exp Neurol 166 2000 287 297
4. H. Benveniste Brain microdialysis J Neurochem 52 1989 1667 1679
5. P.M. Bungay, P.F. Morrison, and R.L. Dedrick Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro Life Sci 46 1990 105 119
6. J. Delforge, M. Bottlaender, S. Pappata, C. Loc'h, and A. Syrota Absolute quantification by positron emission tomography of the endogenous ligand J Cereb Blood Flow Metab 21 2001 613 630
7. S.L. Dewey, J.D. Brodie, J.S. Fowler, R.R. MacGregor, D.J. Schlyer, and P.T. King Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain Synapse 6 1990 321 327
8. S.L. Dewey, G.S. Smith, J. Logan, J.D. Brodie, J.S. Fowler, and A.P. Wolf Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels Synapse 13 1993 350 356
9. S.L. Dewey, A.P. Wolf, J.S. Fowler, J.D. Brodie, C-Y. Shiue, and A. Alavi The effects of central cholinergic blockage on [18F]-N-methylspiroperidol binding in the human brain using PET XVI CINP Congr 96 1988 162
10. D.J. Doudet, S. Jivan, and J.E. Holden In vivo measurement of receptor density and affinity: comparison of the routine sequential method with a nonsequential method in studies of dopamine D2 receptors with [11C]raclopride J Cereb Blood Flow Metab 23 2003 280 284
11. L. Farde, H. Hall, E. Ehrin, and G. Sedvall Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET Science 231 1986 258 261
12. A. Gjedde, and D.F. Wong Quantification of neuroreceptors in living human brain. V. Endogenous neurotransmitter inhibition of haloperidol binding in psychosis J Cereb Blood Flow Metab 21 2001 982 994
13. J.E. Holden, and D.J. Doudet Positron emission tomography receptor assay with multiple ligand concentrations: an equilibrium approach Meth Enzymol 385 2004 169 184
14. G.C. Houston, S.P. Hume, E. Hirani, J.L. Goggi, and P.M. Grasby Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents Synapse 51 2004 206 212
15. S.P. Hume, R.N. Gunn, and T. Jones Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals Eur J Nucl Med 25 1998 173 176
16. S.P. Hume, A.A. Lammertsma, R. Myers, S. Rajeswaran, P.M. Bloomfield, and S. Ashworth The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease J Neurosci Meth 67 1996 103 112
17. S.P. Hume, J. Opacka-Juffry, R. Myers, R.G. Ahier, S. Ashworth, and D.J. Brooks Effect of l-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET Synapse 21 1995 45 53
18. H.I. Kornblum, D.M. Araujo, A.J. Annala, K.J. Tatsukawa, M.E. Phelps, and S.R. Cherry In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET) Nat Biotechnol 18 2000 655 660
19. J. Logan, J.S. Fowler, N.D. Volkow, G.J. Wang, Y.S. Ding, and D.L. Alexoff Distribution volume ratios without blood sampling from graphical analysis of PET data J Cereb Blood Flow Metab 16 1996 834 840
20. J. Logan, N.D. Volkow, J.S. Fowler, G.J. Wang, M.W. Fischman, and R.W. Foltin Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET Synapse 27 1997 347 356
21. D.C. MacLaren, S.S. Gambhir, N. Satyamurthy, J.R. Barrio, S. Sharfstein, and T. Toyokuni Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals Gene Ther 6 1999 785 791
22. S.R. Meikle, S. Eberl, R.R. Fulton, M. Kassiou, and M.J. Fulham The influence of tomograph sensitivity on kinetic parameter estimation in positron emission tomography imaging studies of the rat brain Nucl Med Biol 27 2000 617 625
23. E.D. Morris, S.I. Chefer, and E.D. London Limitations of binding potential as a measure of receptor function: a two-point correction for the effects of mass R.E. Carson M.E. Daube-Witherspoon P. Herscovitch Quantitative Functional Brain Imaging with Positron Emission Tomography 1998 Academic Press 407 414
24. max, and other parameters via multiple-injection positron emission tomography experiments Meth Enzymol 385 2004 184 213
25. R. Myers, S.P. Hume, S. Ashworth, A.A. Lammerstma, P.M. Bloomfield, and S. Rajeswaran Quantification of dopamine receptors and transporter in rat striatum using a small animal PET scanner R. Myers V.J. Cunningham D. Bailey T. Jones Quantification of Brain Function Using PET 1997 Academic Press San Diego, CA 12 15
26. S. Nikolaus, R. Larisch, M. Beu, F. Forutan, H. Vosberg, and H.W. Muller-Gartner Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET Eur J Nucl Med Mol Imaging 30 2003 390 395
27. S. Nikolaus, R. Larisch, M. Beu, K. Hamacher, F. Forutan, and H. Vosberg In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl) benperidol in the rat striatum with a PET system for small laboratory animals J Nucl Med 44 2003 618 624
28. S. Nikolaus, R. Larisch, M. Beu, H. Vosberg, and H.W. Muller-Gartner Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol J Nucl Med 42 2001 1691 1696
29. J. Opacka-Juffry, S. Ashworth, R.G. Ahier, and S.P. Hume Modulatory effects of l-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET J Neural Transm 105 1998 349 364
30. G. Paxinos, and C. Watson The Rat Brain in Stereotoxic Coordinates 1986 Academic Press San Diego, CA
31. J. Qi, R.M. Leahy, S.R. Cherry, A. Chatziioannou, and T.H. Farquhar High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner Phys Med Biol 43 1998 1001 1013
32. K.P. Schafers Imaging small animals with positron emission tomography Nuklearmedizin 42 2003 86 89
33. W.K. Schiffer, D. Alexoff, and S.L. Dewey Microdialysis probe placement produces marked ipsilateral hypometabolism in the absence of similar changes in dopamine receptor activity and extracellular dopamine concentrations Proceedings of the XXIst International Symposium on Cerebral Blood Flow, Metabolism and Function and the VIth International Conference on Quantification of Brain Function with PET Calgary, Alberta, Canada: J Cereb Blood Flow Metab, June 23 2003
34. W.K. Schiffer, M.R. Gerasimov, R.A. Bermel, J.D. Brodie, and S.L. Dewey Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: a PET/microdialysis study Life Sci 66 2000 PL169 PL173
35. W.K. Schiffer, M.R. Gerasimov, D.A. Marsteller, J. Geiger, C. Barnett, and D.L. Alexoff Topiramate selectively attenuates nicotine-induced increases in monoamine release Synapse 42 2001 196 198
36. A.W. Toga, E.M. Santori, R. Hazani, and K. Ambach A 3D digital map of rat brain. Brain Res Bull 38 1995 77 85